DDR2 and ovarian cancer: Interestingly, DDR2 is a key transcriptional target of TWIST1 during cranial mesoderm development [90] and in ovarian cancer cells, where TWIST1-dependent DDR2 expression was critical for EMT, migration, invasion, and in vivo metastasis [91].